5 Stocks You Can Trust… And 20 You Can’t

Stock #4: Amgen (AMGN)

Amgen (AMGN) is in the recession-proof health care sector and has seen strong
sales and earnings even during the recent turmoil on Wall Street.

Amgen is the largest biotechnology company in the world. The company helps patients fight cancer, kidney disease and arthritis.
I’m sure you’ve heard of the medications AMGN sells — its drugs Epogen and Aranesp, which treat anemia, account for more than
one-third of its sales. Enbrel, a leading arthritis drug, is one of the best-selling treatments in this multibillion-dollar market.
Amgen currently has five “blockbuster” drugs like this on the market. Amgen also has a promising drug pipeline and key marketing
alliances.

Recently, the company announced that it expects to have three more drugs on the market over the next five years that are projected
to net $1 billion or more in annual sales each. Now that’s the prescription for continued profits.

I rate AMGN a B or Buy.

NEXT: Stock #5: Apollo (APOL)